Heilongjiang Zbd Pharmaceutical Co.,Ltd.’s Net Profit Dropped 12.5% in First Half of 2022

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (黑龙江珍宝岛药业股份有限公司) (603567.SH) reported a net profit of 243.1 million yuan in the first half of 2022, down 12.5% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 52.2% year-on-year.

At the end of the reporting period, it had 11.8 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 39.2%.